Assertive Outreach for people with schizophrenia

• Conditions: F20; Schizophrenia

• Registration Number: DRKS00003351
• Lead Sponsor: euphana Universität Lüneburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-11-29
• Study Completion: 2013-09-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 341

Inclusion Criteria

We include patients with a diagnosed schizophrenia (ICD-10: F20) and moderate or severe impairments in the level of functioning rated by the physician using the global assessment of functiong scale (GAF = 60).

Exclusion Criteria

-medium or severe cognitive impairments or organic mental disorder
-insufficient language ability
-no capacity to give informed consent to the study participation
-patients who refuse assertive outreach

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of days spent in inpatient psychiatric care (measured with the Client Socio-demografic and Service Receipt Inventory CSSRI)

Secondary Outcome Measures

Name	Time	Method
Psychosocial functioning (patient: WHO-Disability Assessment Scale II 12-Item, physician: Global Assessment of Functioning (GAF))<br>Psychopathology (patient: 2 items from the Alcohol Use and Drug Use Scale, physician: Brief Psychiatric Rating Scale)<br>Life satisfaction (single item measure)<br>Patient satisfaction with care (Patient Assessment of Chronic Care (PACIC short version))<br>Direct and indirect costs (CSSRI)<br>